We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province
California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China
Shook, Hardy & Bacon Intellectual Property Attorney Tom Moga has been cited in the U.S. International Trade Commission’s (ITC’s) May 2011 report on intellectual property rights (IPR) and indigenous innovation policies in China, and how they affect the U.S. economy and employment
Shook, Hardy & Bacon Intellectual Property Attorney Tom Moga has been invited to a June 28, 2011, meeting in Washington, D.C., to discuss developments in innovation and intellectual property policy in China with representatives from the Congressional-Executive Commission on China, U.S.Chamber of Commerce and U.S. Patent & Trademark Office
